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Externally controllable drug delivery systems are crucial for a variety of drug delivery 
applications where the dosage and timing of drug delivery needs to be adjusted based on 
disease diagnosis and progression. Here, we have developed an externally controllable 
drug delivery platform by combining three extensively used platforms: hydrogels, 
liposomes, and single-walled carbon nanotubes (SWCNTs). We have developed carbon 
nanotube-liposome complexes (CLCs) and incorporated these structures into a 3D 
alginate hydrogel for use as an optically controlled drug delivery system. The CLC 
structures were characterized using a variety of imaging and spectroscopic techniques 
and an optimal SWCNT/lipid ratio was selected. The optimal CLCs were loaded with a 
model drug (FITC-Dex), incorporated into a hydrogel, and their release profile was 
studied. It was shown that release of the drug cargo can be triggered using an NIR laser 
stimulation tuned to the optical resonance of a particular SWCNT species. It is further 
shown that the amount of released cargo can be tuned by varying NIR stimulation time. 
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This system demonstrates the externally controlled delivery of drug cargo and can be 
used for different applications including cancer chemotherapy delivery.  
 
Keywords biomaterials, nanotechnology, stimulated drug delivery, single-walled carbon 
nanotubes, liposomes, hydrogels, self-assembly, near-infrared laser stimulation 
 
Introduction 
Externally controllable drug delivery systems are crucial for a variety of applications 
including tissue engineering and cancer chemotherapy. Cancer is the 2nd leading cause 
of death in the United States and affects 40% of Americans during the course of their 
lifetimes. It is estimated that 4,950 new invasive cases will be diagnosed each day in the 
United States in 2020.1 Although many chemotherapeutic drugs have been developed for 
cancer, severe systematic toxicity of these drugs has limited their clinical usage. More 
specifically, the most efficient systems can provide drug accumulation at tumor sites with 
less than 1% efficiency, leaving 99% of the administered drug to adversely affect healthy 
tissues.2 Delivery systems are therefore developed to increase the localized dose and 
effectiveness of the chemotherapeutic drugs at the target sites.3-8 One of the most 
challenging factors in developing these systems is designing a versatile system that can 
be loaded with a variety of payloads rather than individually designed systems for a 
specific payload. Traditionally, delivery systems for specific drugs were developed based 
on modifications of the drug formulation or a chemical bonding of the drug to the drug 
carrier. While these systems have shown promise for some applications, extensive 
research is needed for the design of one drug delivery system applicable for one unique 
drug making this design step a bottleneck in the process. There are a few different design 
approaches that circumvent this issue by providing a platform for drug delivery.  
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Hydrogels have been extensively studied and used for localized drug delivery due to their 
biocompatibility, modifiable properties, and high drug loading capacity.9-12 The hydrogel 
drug delivery systems often utilize degradation rate or other physical/chemical 
parameters of the hydrogel scaffold as a tool to achieve a sustained and controlled 
release rate. However, many cancer conditions require more complex controlled release 
profiles (i.e. on-demand & real time control over release).4, 13, 14 Furthermore, conventional 
hydrogel systems can only be used to deliver hydrophilic drugs, leaving out a major group 
of drugs which are hydrophobic.  
 
Stimuli responsive drug delivery systems are a class of materials developed to provide 
real-time control over drug release. These stimuli can be biological in nature, such as pH, 
temperature, and reactive oxygen species (ROS), or can be external, such as magnetic 
field, ultrasound, electrical field, or light.11, 15-21 To develop an external stimuli responsive 
system, a stimuli responsive moiety is often combined with a drug carrier moiety. 
Therefore, when a stimulus is applied, the responsive moiety triggers a physical or 
chemical change in the carrier moiety that leads to the drug release. Self-assembled 
liposomes offer many adjustable parameters for developing controlled drug delivery 
systems.22 Liposomes are often used as the drug carrier moiety as they can encapsulate 
both hydrophilic and hydrophobic drugs.23, 24 There are many liposomal formulations that 
are currently FDA-approved or are in clinical trials.25 One of the most important limitations 
of liposomal drug delivery is their fast clearance and low retention. To address this 
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limitation, liposome/hydrogel systems are developed. These systems can achieve long-
term drug delivery while utilizing unique properties of both liposomes and hydrogels.26, 27 
Single-walled carbon nanotubes (SWCNTs) are composed of a single graphitic layer 
rolled up into a one-dimensional nanocylinder.28, 29 The existence of an electronic 
bandgap energy in semiconducting SWCNTs results in a variety of unique near-infrared 
(NIR) optical and electronic properties making them ideal candidates for various disparate 
fields including photothermal therapy,30, 31 bioimaging,32, 33 biosensing34, 35 and drug 
delivery.36-39 Their bandgap energies and chiral identities vary based on the roll-up 
direction of the graphitic layer, resulting in various species (chiralities) that differentially 
absorb photons with energies matching the band gap of the E11 optical transition. These 
wavelengths are in the biological tissue-transparency range, including NIR-I (750-1000 
nm) and NIR-II windows (1000-1700 nm)28, which enables NIR-stimulated heating of 
implanted SWCNTs. Various amphiphilic polymers such as short single stranded DNA 
(ssDNA) 40-42 and Phospholipid-Polyethylene glycol (PL-PEG) 43 have been shown to 
effectively wrap around the SWCNTs through noncovalent π-stacking of their 
hydrophobic sections on the SWCNT sidewalls, resulting in enhanced biocompatibility 
and long-term colloidal stability. Solubilized single- or multi-walled carbon nanotubes 
(referred here as CNTs) have shown promise in a variety of biological applications. In 
most drug delivery systems, three main methods are used to induce interactions between 
the active compound (drug) and CNTs. The first method is to use a CNT mesh or bundle 
and entrap the active compounds within the meshes. The second approach involves 
functional attachment of the compound to exterior CNT walls and the last approach is 
using CNT channels as nano-catheters.44 As CNTs are stimuli-responsive and in 
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particular respond to NIR laser, they can also be used as a stimuli responsive moiety in 
developing a drug delivery system. Here, liposomes are employed as triggerable drug 
carriers to prevent passive release of the cargo. This is critical as liposomes offer unique 
features as drug carriers such as compatibility with both hydrophilic and hydrophobic 
drugs, biocompatibility, and tunability. 
 
Herein, we have developed an external stimuli responsive drug release system based on 
DNA-wrapped SWCNTs (DNA-SWCNTs) self-assembled onto model drug (FITC-Dex)-
containing liposomes (lip). We embedded the carbon nanotube-liposome complexes 
(CLCs) into a 3D hydrogel matrix to fabricate an implantable, NIR-responsive, localized 
drug release device (Schematic 1). Cationic liposomes were self-assembled with 
negatively charged DNA-SWCNTs to form CLCs at varying SWCNT/lipid ratios. The 
CLCs were characterized using dynamic light scattering (DLS), and transmission electron 
microscopy (TEM). The structures with optimal conditions were encapsulated into 
alginate hydrogels for enhanced stability and retention. The controlled localized drug 
release was accomplished by selectively heating the (9,4)-SWCNT chirality using an NIR 
laser at 1122 nm, which increased the permeability of the liposomal bilayer and led to the 
stimulated release of CLCs’ cargo.  
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Schematic 1. DNA wrapped single walled carbon nanotubes and liposomes are self-
assembled to carbon nanotube liposome complexes (CLCs) by electrostatic forces and 
encapsulated in a 3D hydrogel matrix. A. Nano-scale components of the system are shown: 
anionic DNA-wrapped SWCNT and cationic liposomes. B. DNA-wrapped SWCNTs and 
liposomes are mixed at different ratios using a syringe and static mixer and CLCs self-assemble 
at this step. C. CLCs are then encapsulated into a covalently crosslinked alginate hydrogel.  
 
Methods 
Materials Polycarbonate membranes (pore size 100 nm), filter supports, 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC); 2-dioleoyl-3-trimethylammonium-propane (DOTAP) 
in chloroform were purchased from Avanti Polar Lipids Inc. (AL, US). Raw powder 
SWCNTs produced by HiPco process were purchased from Nanointegris (QC, Canada). 
Sodium Alginate (Protanal LF20/40) of high molecular weight ( 250 kDa) was provided 
by FMC BioPolymers (Philadelphia, PA). Phosphate buffered saline (PBS) powder, NaCl,  
2-(N-Morpholino)ethanesulfonic acid hydrate (MES hydrate), adipic acid dihydrazide 
(AAD), 1-hydroxybenzotriazole (HOBt), 1-ethyl-3-(dimethylaminopropyl), carbodiimide 
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kDa) were purchased from Sigma Aldrich (MO, US). Desalted ss(GT)15 oligomeric DNA 
and Cy5-ss(GT)15 were purchased from Integrated DNA Technologies (IA, US).  
Preparation of DNA-SWCNT Dispersions Single-stranded DNA was used to non-
covalently wrap the SWCNTs and disperse them in aqueous solutions following a 
previously published method.33 For each dispersion, 1 mg of raw HiPco nanotubes was 
added to 2 mg of desalted ss(GT)15 oligonucleotide in a microcentrifuge tube with 1 mL 
of 100 mM NaCl. The mixtures were then ultrasonicated using a 1/8″ tapered microtip 
(Sonics Vibracell) for 2 h at 40% amplitude, with an average power output of 8 W, in a 0 
°C temperature-controlled microcentrifuge tube holder. The dispersion was 
ultracentrifuged (Sorvall Discovery M120 SE) for 30 min at 250,000 xg and the top 80% 
of the supernatant was extracted. The concentration of the stock DNA-SWCNT dispersion 
(SWCNT solution) was determined by a previously described method. This was done by 
measuring the stock solution absorbance with a UV/vis/NIR spectrophotometer (Jasco, 
Japan) at 910 nm and using the extinction coefficient Abs910nm = 0.02554 L mg-1 cm-1.42, 45-
47 To remove free DNA molecules, Amicon ultracentrifuge filters (Millipore Sigma) with 
100 kDa molecular weight cutoff were used. Filtration was repeated three times for each 
sample, and at each step, the pellets were resuspended in 100 mM NaCl.  
Liposome Fabrication & Characterization Thin lipid film hydration method48 was used 
to form DOPC:DOTAP 1:1 liposomes. Briefly, lipids were mixed at 1:1 molar ratio in 
chloroform at 40 mM total lipid and rotary evaporated (rotavapor R-215 Buchi) in a 50 mL 
round bottom flask to form a thin lipid film. The pressure was decreased from 300 mbar 
to 200 mbar, and finally to 50 mbar (30 min at each pressure). During this step, the 
rotating flask was kept in a water bath at 50 C. After the thin lipid film formation step, 
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flasks were kept under vacuum (25 mbar) overnight for complete drying. Then, 4 mL of 
the model drug solution (3 kDa FITC-Dex in deionized (DI) water) at 1 mg/mL was added 
to each flask. After 5 min of hydration at 45 C, flasks were vortexed, and solutions were 
extruded at room temperature through a polycarbonate membrane (100 nm pores) using 
Avanti Extrusion System to form uniform-sized of unilamellar liposomes. Dynamic light 
scattering (DLS) was used to measure the size and polydispersity index (PDI) of the final 
liposome solution. 
SWCNT-Liposome Complex (CLC) Fabrication and Characterization DNA-SWCNTs 
(at 0, 20, 50 or 100 mg/L) were mixed with FITC-Dex-loaded liposomes (at 5 mM of lipid 
concentration). A syringe pump (NE Pump System Model NE-4000) and a two-barrel 
syringe were used to keep the mixing rate constant and ensure complete mixing of the 
SWCNT and liposome solutions. The samples and SWCNT solution were then analyzed 
using DLS to measure size, PDI, and zeta-potential. Cryo-transition electron microscopy 
(cryo-TEM) was conducted using a JEOL JEM-2100F TEM (Ma, US). It was operated at 
200 kV using a liquid nitrogen cooling stage Model 915, Gatan Inc. (CA, US). 10 mL of 
the sample was deposited onto a Quantfoil copper grid of 200 square mesh purchased 
from Electron Microscopy Sciences (PA, US). The sample grids were inserted in liquid 
ethane using a Vitrobot system (FEI Company, Hillsboro). 
Integration of CLCs into 3D Hydrogels & Passive Release Purified alginate was 
dissolved in MES buffer at 2.5 wt% with 2.5 mM AAD crosslinker and 4.3 mM HOBt. The 
alginate solution (2 mL) was then mixed with CLCs at 2.5 mM lipid and 25 mg/L SWCNT 
(2 mL) using luer-lock syringes and luer-lock connectors. To ensure complete mixing, at 
least 20 passes were performed each time. EDC in MES buffer (1 mL) at 100 mg/mL was 
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used to initiate crosslinking. Two silicone coated glass plates with 2 mm spacers were 
used for gel casting. Individual cylindrical 8 mm2 mm gel disks were cut using biopsy 
punches (Integra Miltex, PA). A three-day rinse (9 times media change) was performed 
in PBS to remove any non-encapsulated drug and crosslinking residues. This rinsing step 
was also used as a purification step to remove any free SWCNT from the system. The 
gels were then kept in 24 well plates in 1 mL of PBS at room temperature in dark and 
media was changed daily. 
Gels were exposed to 0.02% Triton-X 100 (TX-100) solution to disrupt liposomes and 
release their cargo on day 3. Samples were collected daily and confocal microscopy of 
the hydrogels was performed at specific time points (day 3 and day 4) using laser 
scanning microscopy with a Zeiss LSM 700 confocal module. Epifluorescence 
observation with FITC filter was used with the diode laser with an excitation line at 488 
nm. Zeiss ZEN 2011 software was utilized for image analysis. 3D z-stacks of xyz (350 
µm ´350 µm ´250 µm) was obtained using 10 µm step size at day 0 to ensure uniform 
distribution of CLCs within the hydrogel with different SWCNT concentrations. To quantify 
FITC-Dex release, fluorescence spectra of the samples was measured using Cytation 3 
Plate Reader with BioTek Gen5 software using the excitation wavelength of 490 nm and 
the emission wavelength of 520 nm. Standard solutions were prepared with known 
concentrations of FITC-Dex and the standard curve was used for calculating unknown 
concentrations. 
As SWCNTs can affect fluorescence properties of dyes, we performed a control test 
where different concentrations of DNA functionalized SWCNTs were mixed with a 
constant concentration of FITC-Dextran and incubated at room temperature for 1 h. 
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Examined concentrations were 20 mg/L, 10 mg/L and 5 mg/L SWCNT in the final solution 
with a constant FITC-Dex concentration of 1 mg/mL. A Cytation 3 Plate Reader with 
BioTek Gen5 software was used and fluorescence emission spectra was measured using 
excitation wavelength of 490 nm.   
Colocalization of SWCNTs and Liposomes To study colocalization of SWCNT and 
liposomes in CLCs, single stranded DNA was substituted with Cy5-ssDNA where a Cy5 
dye was attached to 5’ end of the DNA strand. All of the other parts of the procedure were 
followed similar to the previously described method: “DNA Wrapping of SWCNT”. These 
Cy5-DNA-SWCNT were then used to fabricate CLCs at 50 mg/L. FITC-Dex 3 kDa at 0.5 
mg/mL was loaded into the liposomes prior to mixing with SWCNTs. These CLCs were 
then integrated into an alginate scaffold and rinsed for one day. Fluorescence confocal 
microscopy was performed using a Zeiss LSM 700 confocal. Epifluorescence observation 
with a Rhodamine filter with an excitation at 555 nm was followed with a FITC filter with 
an excitation line at 488 nm. The middle image of the z-stack was used for colocalization 
analysis. The images from these two channels were overlaid and colocalization analysis 
was conducted with FIJI software using Coloc 2 plugin.  
Confocal Raman Imaging Gels were imaged using a WiTec Alpha300 R confocal 
Raman microscope (WiTec, Germany) equipped with a Zeiss EC Epiplan - Neofluar 10x 
/0.25 objective, a 785 nm laser source set to 30mW sample power, and a WiTec UHTS 
300 CCD detector with a 300 lines/mm grating. The Raman Z-stacks were obtained in 2.5 
X 2.5 µm intervals with 17.5 µm depth between slices and a 0.2 second/spectrum 
integration time to construct hyperspectral Raman volumes within the gels. A global 
background subtraction and cosmic-ray removal was performed using WiTec Control 5.2 
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software on all acquired confocal Raman data.  A calibration curve was obtained by 
recording spectra of known SWCNT concentrations serially diluted in a single pixel 
volume using identical acquisition settings. Using custom Matlab codes, the G-band from 
each spectrum was fit to a Lorentzian curve and the intensity was correlated to the known 
SWCNT concentration to produce linear fit coefficients. The G-band of all spectra from 
the confocal Raman Z-stacks were fit to Lorentzian curves, the intensity was extracted, 
and the calibration coefficients were applied to construct 3D concentration maps of 
SWCNTs in the gels.  
Mechanical Testing of Hydrogels Compression tests were performed on hydrogels 
using an Instron Model 3345 (Norwood, MA). Hydrogels were fabricated and fully swollen 
in PBS for three days before the tests. The stress vs. strain of each gel (8 mm2 mm) 
was recorded while the gel was compressed at a rate of 2 mm/min to up to 70% strain. 
Three gels were tested for each condition. Young’s moduli were calculated using the initial 
linear portion of the curve and the strain of failure was defined as the highest strain before 
the failure (the drop in compressive stress).  
SEM imaging of CLC and alginate gels CLC and alginate gels were imaged using 
scanning electron microscopy to visualize gel’s porous structure. To prepare the samples 
for SEM imaging, each gel was frozen at -20 ºC overnight. Gels were then lyophilized at 
0.05 mbar and -50 ºC for one day. Gels were then cross sectioned using a sharp razor 
blade, sputter coated by gold (coating thickness of 18 nm). Samples were imaged using 
a Zeiss SIGMA VP field emission scanning electron microscope (FE-SEM). Everhart-
Thornley detector was used with 3 kV acceleration voltage and chamber pressure was 
set at 5  10-6 Torr.  
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Heating of CLC Solutions using an NIR Laser We conducted all of the 
heating/stimulating experiments using a laser module with fiber coupling at 1122 nm 
(Model MIL-H-1122-1W) (Changchun New Industries, China). Samples were kept in a 24 
well plate during the experiment (1 mL in each well). The laser was set up to have a 1 cm 
distance from the well. A water bath was set at 37 ºC and plates were kept on the water 
using a stand prior to starting of the experiment (to reach equilibrium) and during the 
experiment. Four different SWCNT concentrations (0 , 10 , 20 and 30 mg/L) were heated 
using the NIR laser at 8.85 kW/m2 . The temperature was recorded using a USB TC-08 
thermocouple data logger (Pico Technology, UK) with 10 seconds time intervals. These 
concentrations were selected because they correspond to the final concentration of 
SWCNT in the gels using initial SWCNT concentrations of 0, 25, 50 and 75 mg/L. A pulsed 
heating experiment was conducted using the 20 mg/L solution where the laser was set at 
60 seconds on, 300 seconds off and the pulse was repeated 5 times.  
Stimulated Release Studies CLCs were fabricated and loaded with 0.5 mg/mL FITC-
Dex 3 kDa using the 50 mg/L SWCNT solution as described previously. Hydrogels were 
fabricated following the previously described method with CLCs or liposomes. The 
hydrogels were cut in 8 mm diameter 2 mm thick cylinders and rinsed 9 times in 3 days 
prior to start of the experiment. Then, each gel was kept in a well of a 24 well plate with 
1 mL PBS for release studies. One set of gels (n=3) were stimulated using the 1122 nm 
laser at 8.85 kW/m2 at 37 °C for 1 h while another set of gels (control at 37 °C) were not 
stimulated. One set of liposome gels (n=3) were exposed to 0.2% TX-100 solution to 
release all of the liposome cargo. Release samples were acquired immediately before 
and 1 day after stimulation (to provide enough time for diffusion from the gel). In another 
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experiment, three sets of CLC encapsulating gels (control, stimulated and TX-100) were 
tested for different time durations (15, 30 or 45 min). Samples were acquired immediately 
before and after stimulation for all of the conditions. Although sampling right after 
stimulation did not provide enough time for all of the drug released from CLCs to diffuse 
out of the hydrogel, it aimed to show differences in instant release for the different NIR 
stimulation time durations. 
Swelling Ratio Measurement before and after NIR Stimulation Swelling ratio of CLC 
gels was measured for two set of gels: 1. control CLC gels at 50 mg/L that were not 
stimulated and 2. stimulated gels: exposed to NIR laser stimulation at 8.85 kW/m2 for 1 
h. Gels were formed following the previously mentioned method and punched into 
individual cylindrical disks (8 mm 2 mm). Each gel was fully swollen and rinsed 9 times 
before the tests. The weights of the swollen gels were measured after removal of excess 
solution by a filter paper. The gels were then frozen overnight at -20 °C and lyophilized at 
0.05 mbar for a day. The weights of dry gels were measured right after their removal from 





where 𝑊𝑠 and 𝑊𝑑 represent weights of the swollen and dried gels, respectively. 
Cytotoxicity of CLC gels in vitro To assess gel and laser stimulation cytotoxicity in vitro, 
Annexin V/ Propidium Iodide apoptosis assay was used on macrophages. RAW 264.7 
TIB-71 cells (ATCC, Manassas, VA, USA) were cultured under standard incubation 
conditions at 37 C and 5% CO2 in cell culture medium containing sterile filtered high-
glucose DMEM with 10% heat-inactivated FBS, 2.5% HEPES, 1% L-glutamine, 1% 
penicillin/ streptomycin, and 0.2% amphotericin B. Media components were acquired from 
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Gibco. RAW 264.7 macrophages were cultured until 80% confluency in 24-well plates, at 
which media (1 mL) was replaced and CLC gels (8 mm diameter and 2 mm thick, rinsed 
9 times) were added to each well. Gels were either stimulated using a 1122 nm laser at 
8.85 kW/m2 or incubated without stimulation for 1 h. Cells were immediately collected 
from each well and stained with annexin V and propidium iodide (Dead Cell Apoptosis Kit 
V13242, Invitrogen) following the manufacturers protocol. Fluorescence images of the 
stained cells were acquired using a Cellometer Vision CBA Image Cytometer (Nexcelom 
Bioscience) and images were analyzed using ImageJ and custom MATLAB codes. Three 
gel samples were used for each condition and total cells of n>6,700 were imaged in 
histograms. Fluorescence data were gated based on control cells cultured without gel 
addition. For this non-gel control, 4 well plates were used with total cells of n>6,700.  
A gel from each group of stimulated or non-stimulated was imaged to capture any visual 
or macroscopic physical changes. 
Statistical Analyses and Data Representation All quantitative data are reported as 
means ± standard deviation of three different samples. Analysis of variance (ANOVA) 
was used with Tukey’s post hoc tests for multiple comparisons to evaluate statistically 
significant differences when multiple groups were compared. When a single pair of 
conditions were analyzed, Student’s t tests were used. p values less than 0.05 was the 
benchmark for statistically significant differences. Symbols *, **, and *** indicate statistical 
significance with p < 0.05, 0.01, and 0.001, respectively. No statistically significant 
difference is indicated by an “n.s.” (p > 0.05). 
 
Results & Discussion 
 15 
SWCNT-Liposome Complex (CLC) Fabrication 
We fabricated SWCNT-liposome complexes (CLCs) through self-assembly by mixing 
DNA-functionalized SWCNTs with cationic liposomes. To study the effect of SWCNT 
solution concentration on the CLCs’ structures, four different concentrations of SWCNT 
solution were tested: 0, 20, 50 and 100 mg/L. We used a previously published method33 
to achieve uniformly dispersed solutions of Hipco SWCNTs.  In their raw form, SWCNTs 
are highly hydrophobic and are insoluble in water. Sonication of SWCNTs with DNA and 
ultracentrifugation to remove aggregates results in a dark, ink-like solution of dispersed 
DNA-SWCNT conjugates. Successful conjugation is further confirmed by the appearance 
of multiple peaks in the NIR and visible range of their absorbance spectrum41, 42 (Figure 
S1). As shown in Figure 1A, the average diameter of the liposomes did not change 
significantly when the 20 mg/L SWCNT solution was introduced. However, when the 
SWCNT solution’s concentration was increased to 50 mg/L and 100 mg/L, the average 
diameter significantly changed compared to the lower concentrations as well as 
compared to the bare liposome (i.e. 0 mg/L) (Figure 1A(i), black bars). It is important to 
note that the polydispersity index also did not change significantly when 20 mg/L of 
SWCNTs were used. The polydispersity index increased significantly compared to the 
bare liposomes (i.e. 0 mg/L) when 50 mg/L or 100 mg/L SWCNT solutions were used 
(Figure 1A(i), green bars). Zeta potentials of the CLC solutions were also measured, and 
a decreasing trend was observed as the SWCNT concentration increased. The zeta 
potential of SWCNT solution at 50 mg/L was -39.8 mV with standard deviation of 5.57. 
Similar to diameter and PDI, no significant changes were noticed when zeta potential of 
20 mg/L was compared with the control (i.e. 0 mg/L). However, zeta potential of CLCs at 
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50 mg/L and 100 mg/L was significantly decreased compared to the control. Despite this 
decrease and significant change, the value of the zeta potential stayed positive. This can 
be attributed to the positive charge of the head groups of DOTAP lipids which are used 
in the fabrication of the self-assembled liposomes. As the DNA functionalized SWCNTs 
have a negative charge, they are electrostatically attracted to these positively charged 
lipids and form self-assembled CLCs. SWCNTs partially coated the liposomes and as a 
result led to partial charge screening of cationic DOTAP headgroups; however, they did 
not change the total charge of the solution to a negative value. When the concentration 
of SWCNTs was increased further (e.g. 200 mg/L), macroscopic aggregations formed, 
and the solution was unstable. The net positive charge of CLCs is desirable as it facilitates 
their prolonged encapsulation within the 3D alginate hydrogel which is a negatively 
charged polymer and limits leakage of CLCs out of the hydrogel. It was concluded that 
the structures of CLCs were defined mainly by the ratio of SWCNTs to liposomes and 
therefore by changing the SWCNT’s solution concentrations while keeping liposome’s 
solution concentration constant, different complexes were formed.  
 
Cryo-TEM imaging was performed to visualize the CLC structures at 50 and 100 mg/L 
SWCNT concentrations. As shown in Figure 1B, complex and abnormal shapes were 
observed at 50 mg/L and 100 mg/L compared to the regular unilamellar liposomes at 0 
mg/L (the left image). As SWCNTs have very low contrast in cryo-TEM imaging, single 
SWCNTs cannot be directly observed but are rather detected by the effects that they 
apply on other higher contrast moieties (e.g. liposomes).41 Although these structures were 
complex in shape, they still demonstrated characteristic liposomal bilayers and did not 
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show macro aggregation when analyzed by DLS. This indicates that SWCNTs were not 
disrupting the bilayers, signifying the preservation of liposomal integrity and the ability to 
encapsulate drugs. This was further verified in drug release experiments.  
 
 
Figure 1. CLCs with different properties (size and charge) are formed by changing 
SWCNT to lipid ratio A. (i) Statistical comparison of average diameters and PDIs for 
different CLCs. (ii) Statistical comparison of zeta potentials for different CLCs. B. Cryo-TEM 
images of liposomes and CLCs at 50 mg/L and 100 mg/L are shown (n=3). 
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The fabricated CLCs were integrated into 3D alginate hydrogels to enhance stability and 
enable on-demand localized drug delivery. CLCs in gels were imaged using confocal 
fluorescence microscopy for all formulations (Figure 2A). The 3D z-stack of images at day 
2 showed uniform distributions of CLCs in the 3D hydrogels (Figure S2). We confirmed 
that FITC-Dex did not interact with the SWCNTs and result in quenched fluorescence at 
the specified concentrations (Figure S3). Cumulative passive release rates were less than 
2% for all of the conditions before the addition of TX-100 (Figure 2B).  It is important to 
note that the rates of passive release for CLCs with 20 mg/L SWCNT was significantly 
higher than the rate of passive release for bare liposome (0 mg/L) in the first two day 
(Figure 2C(i)). The passive release rate of concentrations 50 mg/L and 100 mg/L was not 
significantly different from bare liposome in the first 2 days. This result can be explained 
considering high PDI at 20 mg/L and complex shapes of CLCs that could lead to 
significantly higher leakage rates. As the TX-100 solution was added to disrupt the 
liposomal structures, enhanced release was observed for all of the conditions (Figure 
2A&B). Although this enhanced release rate was slightly higher for 50 mg/L and 100 mg/L 
SWCNT, no statistically significant differences were observed for these concentrations 
compared to the lower concentrations (Figure 2C(ii)). Samples continued to release FITC-
Dex from this time point (day 2) up to day 6. As the drug was released from the liposome 
or CLC structures, some amount of the drug was trapped within the 3D hydrogel structure 
(day 2 to day 6) and was slowly released through a constrained diffusion process. This 
slow diffusion for several days is crucial for some applications as a sustained release is 
required rather than a burst release for these applications.49 These results suggest that 
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this system can provide a sustained release starting at a delayed and controlled time point 
(e.g. day 2 in this experiment or the time of stimulation for stimulated release). 
The release of encapsulated therapeutic components inside of a hydrogel matrix can be 
affected by swelling-dependent changes in diffusivity. Therefore, to understand any 
effects of NIR stimulation on this property, we measured swelling ratio of two set of gels: 
(1) control CLC gels at 50 mg/L that were not stimulated and (2) CLC gels exposed to 
NIR laser stimulation at 8.85 kW/m2 for 1 h. A represented gel from each group was also 
imaged to evaluate any physical changes caused by NIR stimulation (Figure S4A).  
There were no significant differences between swelling ratios of control or NIR stimulated 
gels (Figure S4B). This indicates that in the stimulated release studies, release of cargo 
from gel would be caused by disruption of the CLC structures followed by diffusion of the 
cargo from the gel.  
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Figure 2. CLCs were integrated into 3D hydrogel structures and imaged using confocal 
microscopy. A. Images of the middle layer (z=100 mm) of a z-stack for different CLCs in 
alginate are shown before (day 2) and after (day 3) addition of 0.02% TX-100. B. Percentage 
of cumulative FITC-Dex release vs. time from 50 mg/L CLC loaded in alginate hydrogels are 
demonstrated. C. Statistical comparison of release rates of FITC-Dex from CLCs that were 
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0-2). (ii) Statistical comparison of release rates of FITC-Dex from CLCs that were made using 
different DNA-SWCNT concentrations after the addition of 0.02% TX-100 (day 2-3) (n=4). 
 
CLC Distribution in the 3D Hydrogel and Hydrogel Characterization 
As shown in Figure 3A, the hydrogels were a uniform light gray color (CLC integrated gel, 
“CLC gel”, compared to liposome only gel, “lip gel”) with no visual signs of aggregation. 
This uniform gray color verified relatively even distribution of the CLCs within the 3D 
hydrogel with no macroscopic aggregations. SEM imaging was used to visualize the 
porous structure of control alginate gels and CLC gels and confirmed no noticeable 
differences in porosity of these gels, indicating that CLC encapsulation did disturb the 
covalent crosslinking process of the alginate gels (Figure 3B). The mechanical properties 
of lip gels and CLC gels at 50 mg/L DNA-SWCNT were analyzed. As shown in Figure 3C, 
compressive stress vs. strain was measured for the different gels. While CLC integrated 
gels had similar Young’s moduli compared to liposome integrated gels (Figure 3D(i)); a 
significantly higher strain of failure was recorded for CLC Gels compared to lip gels 
(Figure 3D (ii)). This result is consistent with previous studies that showed enhancement 
of mechanical properties upon the addition of SWCNTs,50 and has been attributed to 
matrix-fiber stress transfer. Fiber length, aspect ratio, dispersion, and alignment 
determine the reinforcement effectiveness. Specifically, it is important to have a dispersed 
SWCNT in the polymer network to achieve efficient load transfer and enhanced 




Figure 3. CLCs distribution in an alginate gel and mechanical properties are shown. A. 
Photos of Lip-gel and CLC-gel (8 mm diameter 2 mm thick) at the DNA-SWCNT 
concentration of 50 mg/L is shown. B. SEM images of control alginate gel and CLC gel 
showed no significant differences in porous structure. C. Compressive stress vs. strain curve 
for a representative CLC gel and a lip gel is demonstrated. D. (i) Statistical comparison of 
Young’s modulus of CLC gels vs. lip gels is shown. (ii) Statistical comparison of the strain of 
failure of CLC gels vs. lip gels are shown (n=3). 
 
Colocalization of the SWCNTs and liposomes was examined by using confocal 
fluorescence microscopy. SWCNTs were dispersed with a fluorescently-tagged Cy5-DNA 
strand (red) and FITC-Dex (green) was used as the model drug loaded inside of the 
liposomes. Imaging of the fluorescently-tagged CLC gels was performed to ensure that 
these moieties are not separated when integrated into the hydrogel construct. Figure S5 
shows an overlaid confocal image and a qualitative colocalization analysis graph 
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corresponding to that image. Results showed an average 70% colocalization. To further 
evaluate SWCNT distribution within the hydrogel, hydrogel volumes of 106 mm3 were 
imaged using confocal Raman microscopy. The intensity of the G-band spectral feature, 
which is linearly correlated to SWCNT concentration,33, 52, 53 was used to visualize the 
localized SWCNT concentration within the gel and the volumetric concentration of 
SWCNTs in the gel was determined (Figure 4). A representative Raman Spectra of 
SWCNT at a random layer and the average of Raman Spectra of all layers are shown in 
Figure S6. There were no significant differences between the average Raman spectra 
and the single layer Raman spectra. 
 
Figure 4. 3D confocal Raman concentration map of SWCNT G-band intensity represents 
localized SWCNT concentrations within a CLC integrated hydrogel (initial 50 mg/L) and the 
volumetric concentration of SWCNTs in the gels is calculated(n=5). 
 
Heating of CLC Solutions using an NIR Laser 
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To evaluate the heating efficiency of the CLCs at specified wavelengths, absorbance 
spectra were acquired (Figure 5A). As expected, absorbance increased with SWCNT 
solution concentration and several distinct peaks, each representing a distinct SWCNT 
chirality,40, 47 were observed in the NIR range (Figure S1). For instance, the measured 
spectra confirm the presence of chiralities of (9,4), (8,6) and (8,7)-SWCNTs in these 
samples. While some methods are available to separate single chiralities of SWCNTs, 
the efficiency of these separation processes are often very low.54 Here, we focused on 
the most pronounced peak, i.e. the (9,4)-SWCNT ~1125 nm. It is important to note that a 
peak around 1200 was also observed (the (8,6)-SWCNT). However, as the deionized 
water (DI) absorption is also significantly higher at this wavelength (pink line), it was not 
chosen for stimulation experiments.  
We next examined the rate of heating of the SWCNT solutions due to laser illumination. 
A 1 W total power 1122 nm laser (8.85 kW/m2) was used for all heating experiments with 
the distance between samples and the laser tip held constant at 1 cm. All experiments 
were conducted in a 37 C water bath. As shown in Figure 5B(i), by increasing SWCNT 
concentration, T(°C) vs. time increased. The maximum T’s were compared for the 
different SWCNT concentrations and a statistically higher maximum T(°C) was obtained 
for a higher SWCNT concentration compared to a lower concentration (Figure 5B(ii)). To 
understand the kinetics of the heating dissipation phenomena, a pulsed heating of 60 
seconds on, 300 seconds off was applied on the SWCNT solution at 20 mg/L. As shown 
in Figure 5C, the temperature reached 46 °C by the first 60 second laser pulse. However, 
when the laser was turned off, the heat quickly dissipated, and the temperature 
approached 37 °C in less than 300 seconds. This trend was repeated in the next on and 
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off cycles. Quantification of average slopes of heating and cooling was conducted and 
verified similar heating and cooling for all of the cycles (Figure S7).  
 
 
Figure 5. Absorbance spectra and heating rate of CLCs are demonstrated. A. 
Absorbance spectra of CLCs at different SWCNT concentrations. B. (i) ∆T (°C) of SWCNT 
solutions vs. time at different concentrations are shown for 100 seconds heating at 1122 nm, 
1 W. (ii) Statistical comparison of maximum ∆T (°C) for different SWCNT concentrations. C. 
Temperature vs. time is shown for pulsed heating (60 seconds on, 300 seconds off) for the 
SWCNT solution at 20 mg/L (n=3). 
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Stimulated Release Studies 
Finally, we demonstrated the stimulated release of FITC-Dex (3 kDa) from CLCs in a 
hydrogel using an 1122 nm laser. CLCs at 50 mg/L SWCNT were used for all of the 
stimulated experiments for CLC encapsulated gels. As shown in Figure 5A, each gel was 
stimulated at 1 W using an 1122 nm laser for 1 h and its release was compared to a 
control (same gel with no stimulation). Significantly higher amounts of FITC-Dex (3 kDa) 
were released from the laser stimulated gels compared to non-stimulated control gels 
(red bar compared with blue bar in Figure 5A(ii)). Release from liposome-encapsulated 
gels (with no SWCNT) was also measured and no significant difference was noticed for 
release from liposomes in gels with or without stimulation (purple bar compared with 
green bar). Tx-100 solution was used as a positive control to release all the cargo (black 
bar in Figure 5A(ii)). This experiment shows that 1 h of stimulation at 1122 nm leads to 
release rates comparable with release from gels exposed to Tx-100 and suggests that 
shorter stimulation durations can be used to stimulate release from CLCs in gel. To 
understand the effect of stimulation duration on release, a few different and shorter 
stimulation times were applied (i.e. 15, 30 and 45 min) on CLC gels with three different 
conditions: control, stimulated and TX-100. 
Adding 0.02% TX-100 solution to the gels resulted in significantly higher release rates 
compared to control or stimulated gels for all the stimulation durations (Figure 5B, black 
bars compared to blue and red bars). This significantly higher release rate was expected 
as TX-100 disrupts the liposomal bilayers and leads to a total release of the encapsulated 
drug. While different durations did not have a significant effect on the release rate from 
the control group, the longest stimulation time (45 min) had a significantly higher release 
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rate compared to the shorter stimulation times (30 min and 15 min). Although there was 
not a significant difference between the release of 15 min and 30 min stimulations, 30 min 
stimulation caused slightly higher release compared to the 15 min stimulation and there 
does appear to be a manifest trend of increased release vs. NIR stimulation duration 
(Figure 5B(ii): upward “stairstep” vs. duration). Thus, it may be possible to externally 
regulate the amount of drug release from these structures through the duration of NIR 
stimulation. Additionally, while not demonstrated here, laser could also provide a means 
to externally regulate the amount of delivered payload triggered by stimulation events. It 
is of note that all of the stimulations used here caused a bulk temperature increase of less 
than 4 C (keeping the bulk temperature below 42 C). This could significantly prevent 
tissue damage from heating and could also help preserve the bioactivity of encapsulated 
and delivered payloads. It is known that bulk temperatures of more than 42 C (i.e. 46 C 
or 49 C) can lead to permanent cell damage and cause tissue toxicity.55 If desired, the 
CLC gel system can be modified to show a combined photothermal therapy and 





Figure 6. FITC-Dex release from CLCs in alginate hydrogels could be stimulated using 
NIR laser. A. (i) Cumulative FITC-Dex release when 1 h stimulation at 1122 nm and 1 W was 
applied. (ii)  Statistical comparison of release rate for control and stimulated (1122 nm for 1 h) 
Lip, CLC and TX-100 samples in hydrogel. B. (i) The release rate for the control, stimulated 
and TX-100 CLC in hydrogel with different stimulation times is demonstrated. (ii) Statistical 
comparison of release rate for the stimulated CLCs in hydrogels of different stimulation 
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Cytotoxicity of CLC gels in vitro  
One of the concerns with photothermally induced drug delivery systems is that they can 
cause side effects and toxicity to the tissue if the power intensity or temperature 
increase is too high. Moreover, SWCNTs have a high binding capacity to biological 
molecules, and if leaching from the gel occurs, can interact with live cells. Macrophages 
would be the first line of defense in such a scenario.56 Therefore, RAW 264.7 
macrophages were selected as the cell line to examine potential adverse effects from 
the stimulated system. To assess toxicity effects of the gel itself and gel with 1 h NIR 
stimulation, Annexin V/ Propidium Iodide apoptosis assay was used. Two-dimensional 
scatter plots were created to display the results of these assays (Figure 7). In these 
graphs, viable cells are shown at the bottom-left quadrant. The top-right quadrant shows 
necrotic cells, bottom-right quadrant shows apoptotic cells and top-left quadrant shows 
debris and cell junk. As there is not a significant difference between the necrotic and 
apoptotic cells for the different conditions, it can be concluded that the gels and NIR 
stimulation have minimal toxicity effects on macrophages in vitro.  To assess the 
cytotoxicity of this system further, other cell lines in vitro and in vivo animal models 




Figure 7. Cytotoxicity assays of macrophages exposed to CLC gels with or without NIR 
stimulation. A. Two-dimensional scatter of control cells not exposed to CLC gels or 
stimulation. B. Cells exposed to CLC gels with no stimulation. C. Cells exposed to CLC gels 
and stimulated with 1122 nm laser at 8.85 kW/m2 for 1 h.  
  
Conclusion 
In this study, we developed SWCNT-liposome complexes (CLC) for controlled triggered 
release. It was shown that the CLC structure is defined by the SWCNT/lipid ratio and an 
optimal ratio was selected for triggered release. Then, CLCs were integrated within a 
3D hydrogel and it was shown that a model drug (FITC-Dex) can be retained for several 
days. Furthermore, an NIR laser was used to stimulate release of the model drug from 
the CLCs in the hydrogel scaffold. It was shown that stimulation time can be modified to 
modify the amount of drug release. To understand the cytotoxicity effects of CLC and 
NIR stimulation, Annexin V/ Propidium Iodide apoptosis assay was used on RAW 264.7 
macrophages and minimal toxicity was noticed in vitro. Further studies need to be 
conducted to investigate the application of this drug delivery system for delivering 
B CA
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specific cancer chemotherapeutics at delayed time points and in vivo application of this 
drug delivery system.  
 
Acknowledgment 
This work was supported in part by the National Science Foundation Established 
Program to Stimulate Competitive Research (EPSCoR) under award OIA-1655221. This 
work is also supported by NSF award #1603433. We would like to acknowledge the 
EPSCoR grant for supporting RIN2 and the Witec. We would like to acknowledge 
genomic and sequencing center at URI for allowing use of confocal microscopy. We 
would like to acknowledge Irene Andreu at RI Consortium for Nanoscience and 
Nanotechnology for conducting SEM imaging, Cryo-TEM imaging and helping with the 




S1. Absorbance spectra of DNA functionalized SWCNT 
S2. 3D z-stack of fluorescence confocal images of CLC gels at day 2 
S3. Fluorescence emission spectra of 1 mg/mL FITC-Dex in presence of different 
SWCNT concentrations 
S4. Images and swelling ratio of CLC gels before and after NIR laser stimulation 
S5. Colocalization analysis of Cy5 (attached to DNA strand on SWCNT) and FITC-
Dex (encapsulated in liposome core) 
S6. Representative Raman spectra at a random layer and average Raman spectra 
of all layers 













1. Siegel, R. L.;  Miller, K. D.; Jemal, A., Cancer statistics, 2020. CA: A Cancer Journal for 
Clinicians 2020, 70 (1), 7-30. 
2. Cao, D.;  Zhang, X.;  Akabar, M.;  Luo, Y.;  Wu, H.;  Ke, X.; Ci, T., Liposomal doxorubicin 
loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of 
breast cancer. Artificial cells, nanomedicine, and biotechnology 2019, 47 (1), 181-191. 
3. Krukiewicz, K.; Zak, J. K., Biomaterial-based regional chemotherapy: Local anticancer 
drug delivery to enhance chemotherapy and minimize its side-effects. Materials Science and 
Engineering: C 2016, 62, 927-942. 
4. Chew, S. A.; Danti, S., Biomaterial‐Based Implantable Devices for Cancer Therapy. 
Advanced healthcare materials 2017, 6 (2), 1600766. 
5. De Souza, R.;  Zahedi, P.;  Allen, C. J.; Piquette-Miller, M., Polymeric drug delivery 
systems for localized cancer chemotherapy. Drug delivery 2010, 17 (6), 365-375. 
6. Tiwari, A. P.;  Hwang, T. I.;  Oh, J.-M.;  Maharjan, B.;  Chun, S.;  Kim, B. S.;  Joshi, M. K.;  
Park, C. H.; Kim, C. S., pH/NIR-responsive polypyrrole-functionalized fibrous localized drug-
delivery platform for synergistic cancer therapy. ACS applied materials & interfaces 2018, 10 
(24), 20256-20270. 
7. Wolinsky, J. B.;  Colson, Y. L.; Grinstaff, M. W., Local drug delivery strategies for cancer 
treatment: gels, nanoparticles, polymeric films, rods, and wafers. Journal of controlled release 
2012, 159 (1), 14-26. 
8. Alvarez, M. M.;  Aizenberg, J.;  Analoui, M.;  Andrews, A. M.;  Bisker, G.;  Boyden, E. S.;  
Kamm, R. D.;  Karp, J. M.;  Mooney, D. J.; Oklu, R., Emerging trends in micro-and nanoscale 
technologies in medicine: From basic discoveries to translation. ACS Publications: 2017. 
9. Emi, T. T.;  Barnes, T.;  Orton, E.;  Reisch, A.;  Tolouei, A. E.;  Madani, S. Z. M.; Kennedy, S. 
M., Pulsatile Chemotherapeutic Delivery Profiles Using Magnetically Responsive Hydrogels. ACS 
biomaterials science & engineering 2018, 4 (7), 2412-2423. 
10. Madani, S. Z. M.;  Reisch, A.;  Roxbury, D.; Kennedy, S. M., A Magnetically Responsive 
Hydrogel System for Controlling the Timing of Bone Progenitor Recruitment and Differentiation 
Factor Deliveries. ACS Biomaterials Science & Engineering 2020, 6 (3), 1522-1534. 
11. Li, J.; Mooney, D. J., Designing hydrogels for controlled drug delivery. Nature Reviews 
Materials 2016, 1 (12), 1-17. 
12. Khang, M. K.;  Zhou, J.;  Huang, Y.;  Hakamivala, A.; Tang, L., Preparation of a novel 
injectable in situ-gelling nanoparticle with applications in controlled protein release and cancer 
cell entrapment. RSC advances 2018, 8 (60), 34625-34633. 
13. Anirudhan, T.; Christa, J., Temperature and pH sensitive multi-functional magnetic 
nanocomposite for the controlled delivery of 5-fluorouracil, an anticancer drug. Journal of Drug 
Delivery Science and Technology 2020, 55, 101476. 
14. Delcassian, D.; Patel, A. K., Nanotechnology and drug delivery. In Bioengineering 
Innovative Solutions for Cancer, Elsevier: 2020; pp 197-219. 
15. Cheng, W.;  Gu, L.;  Ren, W.; Liu, Y., Stimuli-responsive polymers for anti-cancer drug 
delivery. Materials Science and Engineering: C 2014, 45, 600-608. 
 33 
16. Oshiro-Júnior, J. A.;  Rodero, C.;  Hanck-Silva, G.;  Sato, M. R.;  Alves, R. C.;  Eloy, J. O.; 
Chorilli, M., Stimuli-responsive Drug Delivery Nanocarriers in the Treatment of Breast Cancer. 
Current medicinal chemistry 2020, 27 (15), 2494-2513. 
17. Yang, H.;  Khan, A. R.;  Liu, M.;  Fu, M.;  Ji, J.;  Chi, L.; Zhai, G., Stimuli-responsive 
polymeric micelles for the delivery of paclitaxel. Journal of Drug Delivery Science and 
Technology 2020, 101523. 
18. Yang, K.;  Feng, L.; Liu, Z., Stimuli responsive drug delivery systems based on nano-
graphene for cancer therapy. Advanced drug delivery reviews 2016, 105, 228-241. 
19. Cezar, C. A.;  Kennedy, S. M.;  Mehta, M.;  Weaver, J. C.;  Gu, L.;  Vandenburgh, H.; 
Mooney, D. J., Biphasic ferrogels for triggered drug and cell delivery. Advanced healthcare 
materials 2014, 3 (11), 1869-1876. 
20. Kennedy, S.;  Hu, J.;  Kearney, C.;  Skaat, H.;  Gu, L.;  Gentili, M.;  Vandenburgh, H.; 
Mooney, D., Sequential release of nanoparticle payloads from ultrasonically burstable capsules. 
Biomaterials 2016, 75, 91-101. 
21. Kennedy, S.;  Roco, C.;  Déléris, A.;  Spoerri, P.;  Cezar, C.;  Weaver, J.;  Vandenburgh, H.; 
Mooney, D., Improved magnetic regulation of delivery profiles from ferrogels. Biomaterials 
2018, 161, 179-189. 
22. Moosavian, S. A.;  Bianconi, V.;  Pirro, M.; Sahebkar, A. In Challenges and pitfalls in the 
development of liposomal delivery systems for cancer therapy, Seminars in cancer biology, 
Elsevier: 2019. 
23. Chen, Y.;  Bose, A.; Bothun, G. D., Controlled release from bilayer-decorated 
magnetoliposomes via electromagnetic heating. ACS nano 2010, 4 (6), 3215-3221. 
24. Preiss, M. R.; Bothun, G. D., Stimuli-responsive liposome-nanoparticle assemblies. Expert 
opinion on drug delivery 2011, 8 (8), 1025-1040. 
25. Beltrán-Gracia, E.;  López-Camacho, A.;  Higuera-Ciapara, I.;  Velázquez-Fernández, J. B.; 
Vallejo-Cardona, A. A., Nanomedicine review: clinical developments in liposomal applications. 
Cancer Nanotechnology 2019, 10 (1), 11. 
26. Thirumaleshwar, S.;  K Kulkarni, P.; V Gowda, D., Liposomal hydrogels: a novel drug 
delivery system for wound dressing. Current drug therapy 2012, 7 (3), 212-218. 
27. Sirousazar, M.;  Taleblou, N.; Roufegari-Nejad, E., Hydrogel and nanocomposite hydrogel 
drug-delivery systems for treatment of cancers. In Materials for Biomedical Engineering, 
Elsevier: 2019; pp 293-329. 
28. Hong, G.;  Diao, S.;  Antaris, A. L.; Dai, H., Carbon nanomaterials for biological imaging 
and nanomedicinal therapy. Chemical reviews 2015, 115 (19), 10816-10906. 
29. Zheng, M.;  Jagota, A.;  Strano, M. S.;  Santos, A. P.;  Barone, P.;  Chou, S. G.;  Diner, B. A.;  
Dresselhaus, M. S.;  Mclean, R. S.; Onoa, G. B., Structure-based carbon nanotube sorting by 
sequence-dependent DNA assembly. Science 2003, 302 (5650), 1545-1548. 
30. Liang, C.;  Diao, S.;  Wang, C.;  Gong, H.;  Liu, T.;  Hong, G.;  Shi, X.;  Dai, H.; Liu, Z., Tumor 
metastasis inhibition by imaging‐guided photothermal therapy with single‐walled carbon 
nanotubes. Advanced materials 2014, 26 (32), 5646-5652. 
31. Zhou, F.;  Wu, S.;  Wu, B.;  Chen, W. R.; Xing, D., Mitochondria‐targeting single‐walled 
carbon nanotubes for cancer photothermal therapy. Small 2011, 7 (19), 2727-2735. 
32. Beyene, A. G.;  Delevich, K.;  Del Bonis-O’Donnell, J. T.;  Piekarski, D. J.;  Lin, W. C.;  
Thomas, A. W.;  Yang, S. J.;  Kosillo, P.;  Yang, D.; Prounis, G. S., Imaging striatal dopamine 
 34 
release using a nongenetically encoded near infrared fluorescent catecholamine nanosensor. 
Science advances 2019, 5 (7), eaaw3108. 
33. Gravely, M.;  Safaee, M. M.; Roxbury, D., Biomolecular Functionalization of a 
Nanomaterial To Control Stability and Retention within Live Cells. Nano letters 2019, 19 (9), 
6203-6212. 
34. Budhathoki-Uprety, J.;  Shah, J.;  Korsen, J. A.;  Wayne, A. E.;  Galassi, T. V.;  Cohen, J. R.;  
Harvey, J. D.;  Jena, P. V.;  Ramanathan, L. V.; Jaimes, E. A., Synthetic molecular recognition 
nanosensor paint for microalbuminuria. Nature communications 2019, 10 (1), 1-9. 
35. Harvey, J. D.;  Baker, H. A.;  Ortiz, M. V.;  Kentsis, A.; Heller, D. A., HIV detection via a 
carbon nanotube RNA sensor. ACS sensors 2019, 4 (5), 1236-1244. 
36. Saleemi, M.;  Kong, Y.;  Yong, P.; Wong, E., An overview of recent development in 
therapeutic drug carrier system using carbon nanotubes. Journal of Drug Delivery Science and 
Technology 2020, 101855. 
37. Zhang, W.;  Zhang, Z.; Zhang, Y., The application of carbon nanotubes in target drug 
delivery systems for cancer therapies. Nanoscale research letters 2011, 6 (1), 555. 
38. Miyako, E.;  Kono, K.;  Yuba, E.;  Hosokawa, C.;  Nagai, H.; Hagihara, Y., Carbon 
nanotube–liposome supramolecular nanotrains for intelligent molecular-transport systems. 
Nature communications 2012, 3 (1), 1-9. 
39. Karchemski, F.;  Zucker, D.;  Barenholz, Y.; Regev, O., Carbon nanotubes-liposomes 
conjugate as a platform for drug delivery into cells. Journal of Controlled Release 2012, 160 (2), 
339-345. 
40. Jena, P. V.;  Safaee, M. M.;  Heller, D. A.; Roxbury, D., DNA–carbon nanotube 
complexation affinity and photoluminescence modulation are independent. ACS applied 
materials & interfaces 2017, 9 (25), 21397-21405. 
41. Safaee, M. M.;  Gravely, M.;  Lamothe, A.;  McSweeney, M.; Roxbury, D., enhancing the 
thermal Stability of carbon nanomaterials with DnA. Scientific reports 2019, 9 (1), 1-11. 
42. Safaee, M. M.;  Gravely, M.;  Rocchio, C.;  Simmeth, M.; Roxbury, D., DNA sequence 
mediates apparent length distribution in single-walled carbon nanotubes. ACS applied materials 
& interfaces 2018, 11 (2), 2225-2233. 
43. Godin, A. G.;  Varela, J. A.;  Gao, Z.;  Danné, N.;  Dupuis, J. P.;  Lounis, B.;  Groc, L.; 
Cognet, L., Single-nanotube tracking reveals the nanoscale organization of the extracellular 
space in the live brain. Nature nanotechnology 2017, 12 (3), 238-243. 
44. Cirillo, G.;  Hampel, S.;  Spizzirri, U. G.;  Parisi, O. I.;  Picci, N.; Iemma, F., Carbon 
Nanotubes Hybrid Hydrogels in Drug Delivery: A Perspective Review. BioMed Research 
International 2014, 2014, 825017. 
45. Galassi, T. V.;  Jena, P. V.;  Shah, J.;  Ao, G.;  Molitor, E.;  Bram, Y.;  Frankel, A.;  Park, J.;  
Jessurun, J.; Ory, D. S., An optical nanoreporter of endolysosomal lipid accumulation reveals 
enduring effects of diet on hepatic macrophages in vivo. Science translational medicine 2018, 
10 (461), eaar2680. 
46. Harvey, J. D.;  Jena, P. V.;  Baker, H. A.;  Zerze, G. H.;  Williams, R. M.;  Galassi, T. V.;  
Roxbury, D.;  Mittal, J.; Heller, D. A., A carbon nanotube reporter of microRNA hybridization 
events in vivo. Nature biomedical engineering 2017, 1 (4), 1-11. 
 35 
47. Roxbury, D.;  Jena, P. V.;  Williams, R. M.;  Enyedi, B.;  Niethammer, P.;  Marcet, S.;  
Verhaegen, M.;  Blais-Ouellette, S.; Heller, D. A., Hyperspectral microscopy of near-infrared 
fluorescence enables 17-chirality carbon nanotube imaging. Scientific reports 2015, 5 (1), 1-6. 
48. Zhang, H., Thin-film hydration followed by extrusion method for liposome preparation. 
In Liposomes, Springer: 2017; pp 17-22. 
49. Norouzi, M.;  Nazari, B.; Miller, D. W., Injectable hydrogel-based drug delivery systems 
for local cancer therapy. Drug discovery today 2016, 21 (11), 1835-1849. 
50. Coleman, J. N.;  Khan, U.;  Blau, W. J.; Gun’ko, Y. K., Small but strong: a review of the 
mechanical properties of carbon nanotube–polymer composites. Carbon 2006, 44 (9), 1624-
1652. 
51. Spitalsky, Z.;  Tasis, D.;  Papagelis, K.; Galiotis, C., Carbon nanotube–polymer composites: 
chemistry, processing, mechanical and electrical properties. Progress in polymer science 2010, 
35 (3), 357-401. 
52. Jin, S.;  Wijesekara, P.;  Boyer, P. D.;  Dahl, K. N.; Islam, M. F., Length-dependent 
intracellular bundling of single-walled carbon nanotubes influences retention. Journal of 
Materials Chemistry B 2017, 5 (32), 6657-6665. 
53. Holt, B. D.;  Dahl, K. N.; Islam, M. F., Quantification of uptake and localization of bovine 
serum albumin‐stabilized single‐wall carbon nanotubes in different human cell types. Small 
2011, 7 (16), 2348-2355. 
54. Yang, F.;  Wang, M.;  Zhang, D.;  Yang, J.;  Zheng, M.; Li, Y., Chirality Pure Carbon 
Nanotubes: Growth, Sorting, and Characterization. Chemical Reviews 2020. 
55. Zhang, Y.;  Zhan, X.;  Xiong, J.;  Peng, S.;  Huang, W.;  Joshi, R.;  Cai, Y.;  Liu, Y.;  Li, R.; 
Yuan, K., Temperature-dependent cell death patterns induced by functionalized gold 
nanoparticle photothermal therapy in melanoma cells. Scientific reports 2018, 8 (1), 1-9. 
56. Huber, L. C.;  Jüngel, A.;  Distler, J. H.;  Moritz, F.;  Gay, R. E.;  Michel, B. A.;  Pisetsky, D. 
S.;  Gay, S.; Distler, O., The role of membrane lipids in the induction of macrophage apoptosis by 
































SEM image of CLC gel
Confocal image of FITC-Dextran 
encapsulated CLC GelCryo-TEM of CLC
Responsive to External 
Near Infrared Laser 
Stimulation
200 nm
200 µm
